bibliographic entry 10330642 [be/10330642]
https://w3id.org/oc/corpus/be/10330642

is a

• bibliographic reference

content

• Yonesaka, K, Zejnullahu, K, Okamoto, I, Satoh, T, Cappuzzo, F, Souglakos, J. Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab. Sci Transl Med (2011) 3: 99ra86. DOI: 10.1126/scitranslmed.3002442 PMID: 21900593

references

• https://w3id.org/oc/corpus/br/254073